Marc Rübsam — German Cancer Research Center

Area of research

Molecular Biology · Pharmacology

Research interest

Research interests include PI3K/AKT/mTOR signaling in cancer, CRISPR and Genetic Engineering, Phosphodiesterase function and regulation, and Cholinesterase and Neurodegenerative Diseases.

Recent publications

Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial

Clinical Cancer Research 2023cited by 13position: middledoi

Abstract CT087: Phase I/II study of the WEE1 inhibitor adavosertib in combination with carboplatin in children with advanced malignancies: arm C of the AcSé-ESMART trial

Cancer Research 2023cited by 1position: middledoi

131O A composite biomarker for evaluation of homologous recombination repair deficiency in a pan-cancer cohort

Annals of Oncology 2023cited by 1position: firstdoi

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy

ESMO Open 2022cited by 14position: middledoi

Single-Color Fluorescence Lifetime Cross-Correlation Spectroscopy In Vivo

Biophysical Journal 2020cited by 14position: middledoi

Evolthon: A community endeavor to evolve lab evolution

PLoS Biology 2019cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Molecular Biology · Pharmacology →